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illuminate the fate of organ-specific T cell clones, partic-
ularly for class I±restricted TCRs. At one extreme, a
passive process of clonal ignorance can account for
Summary the absence of spontaneous autoaggression by CD81 T
cells carrying receptors to lymphocytic choriomeningitis
T cell receptor (TCR) transgenic mice specific for hen virus glycoprotein expressed in the pancreatic islets
egg lysozyme (HEL) were crossed with mice express- (Ohashi et al., 1991). On the other hand, active tolerance
ing HEL on the thyroid epithelium, on pancreatic islet by clonal deletion, accompanied in some instances by
b cells, or systemically. Depending on the pattern of apparent ignorance in residual low avidity cells or an-
HEL expression, deletion of double-positive thymo- ergy, occurs in CD8 T cells reactive to H-2 Kb, SV40 T
cytes ranged fromminimal to complete, and peripheral antigen, or Ld expressed at high levels in the exocrine
CD4 cells exhibited graded reduction in TCR expres- or endocrine pancreas and at very low levels in the
sion, in vitro responsiveness, and in vivo helper ability. thymus (Fields and Loh, 1992; Heath et al., 1992, 1995b;
CD4 cells were least tolerant in TCR/thyroid-HEL and Miller and Heath, 1993; Jolicoeur et al., 1994; Antonia
TCR/islet-HEL mice, which developed an extensive et al., 1995). Graded degrees of peripheral T cell unre-
lymphocytic thyroiditis or insulitis that nevertheless sponsiveness and TCR modulation, without deletion,
did not eliminate HEL-expressing endocrine cells. Au- were also associated with tolerance to Kb expressed in
toreactive CD4 clones thus escape the thymus under the liver, glial cells, or skin keratinocytes (Schonrich et
a range of circumstances, retain sufficient function al., 1991, 1992b; Ferber et al., 1994).
to initiate subclinical autoimmune inflammation when There are few transgenic models in which the regula-
self-antigens are concentrated in the thyroid or pan- tion of organ-specific CD41 clones can be directly as-
sessed. Given the necessity of CD41 T cells for patho-creas, and may regulate progression of subclinical
genesis in many animal models of autoimmunity (Konginflammation to destructive autoimmune disease.
et al., 1989; Wraithet al., 1989; Yagi et al., 1992; Jameson
et al., 1994) and the linkage of human autoimmune dis-
ease to the major histocompatibility (MHC) class II re-
Introduction gion (Todd et al., 1987; Altmann et al., 1991) , it seems
important to understand the nature of tolerance in this
Elucidating the mechanisms for tolerance to self-anti- T cell compartment. Transgenic mice expressing class II
gens in health is important in order to understand the restricted TCRs obtained from clones that had escaped
pathogenesis of autoimmune disease. For ubiquitously tolerance to myelin basic protein (MBP) or an unidenti-
expressed self-antigens, tolerance in the T cell compart- fied pancreatic islet protein in autoimmune mice have
ment has been convincingly shown to result from thymic shown that these cells are either not made actively toler-
deletion (Kappler et al., 1987; Kisielow and von Boeh- ant or manage to escape regulation by other cells in the
mer, 1995) or from an anergic state (Blackman et al., milieu of a transgenic repertoire (Goverman et al., 1993;
1990; Ramsdell and Fowlkes, 1990) that may lead to Katz et al., 1993; Lafaille et al., 1994). By contrast,
eventual peripheral deletion (Fink et al., 1992; Dillon et crosses of class II±restricted TCR transgenic mice with
al., 1995). How tolerance is maintained to tissue-specific animals expressing SV40 T antigen or influenza hemag-
self-antigens, on the other hand, is much less clear. glutinin (HA) in the pancreatic islets have shown active
Subclinical autoimmune inflammation occurs spontane- tolerance or regulation (Degermann et al., 1994; Scott
ously in the thyroid glands of 5%±20% of otherwise et al., 1994; Forster et al., 1995). In the mice expressing
healthy individuals (Weetman, 1991), indicating that tol- SV40 T antigen, self-reactive CD41 T cell number was
erance to this tissue is particularly fragile. Moreover, the reduced and the remaining T cells were hyporesponsive,
ability to induce transient autoimmunity by immunization provided the precursor frequency of autoreactive T cells
with tissue-specific antigens in adjuvant (Paterson, was 30% of CD41 cells or less (Forster et al., 1995). In
1966) has suggested that actively acquired tolerance to animals with HA synthesis in the islets, no intrinsic
a variety of organ-restricted antigens either fails tooccur change in the autoreactive CD41 cells was found, but
or can easily be broken. Consistent with the former hy- active ªclonal diversionº away from a T helper 1 (Th1)±
pothesis, several transgenic mouse models expressing like response was suggested to explain the lack of insu-
a neo-self-antigen exclusively in a particular tissue re- litis in a BALB/c background compared to insulitis and
diabetes ina B10genetic background (Scott et al.,1994).tain normal reactivity to immunogenic forms of the same
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Here, we use five different hen egg lysozyme (HEL)±
expressing transgenic mouse lines bred to a single class
II±restricted TCR transgenic line to compare directly the
fate of autoreactive CD41 T cells recognizing a well-
defined antigen expressed either in the thyroid gland,
pancreas, or systemically. Double-transgenic mice with
different patterns of self-HEL expression display graded
degrees of T cell tolerance induction, in terms of thymic
deletion, peripheral T cell phenotype, and functional re-
sponsiveness. Tolerance does not abolish respon-
siveness of CD41 clones, but instead shifts their sensi-
tivity to TCR stimulation. Organ-specific autoreactive
CD41 cells appear to retain sufficient TCR sensitivity to
be reactivated by high concentrations of autoantigen in
a discrete organ. We suggest that this reactivation may
under different circumstances actively reinforce toler-
ance or provoke autoimmunity.
Results
Panel of HEL-Expressing Mice
Five different HEL-expressing transgenic mouse lines
were generated in the C57BL/6 strain and used in this
study. ML-5 transgenic mice use the metallothionein
promoter to express soluble HEL (sHEL) in the systemic
circulation at a level of 10±20 ng/ml (10±9 M) (Goodnow
et al., 1988). KLK-4 transgenic mice express membrane-
bound HEL (mHEL) on most cells and tissues under
the direction of the ubiquitous H-2 Kb class I promoter
(Hartley et al., 1991). Conversion of sHEL to this mem-
brane-bound form, by addition of the Kb MHC class I
transmembrane and cytoplasmic region, markedly en-
hances the processing of the antigen into the class II
presentation pathway (Brooks et al., 1991). In the TLK-1
and TLK-2 lines, the rat thyroglobulin promoter directs
Figure 1. HEL Expression in Thyroid of TLK-2 and Islets from ILK-3expression of mHEL to the thyroid epithelium (Figure
Transgenic Mice1A). TLK-2 transgenic mice express HEL at somewhat
(A and C) Frozen sections (10 mm) of thyroid from TLK-2 transgenichigher levels and on more thymocytes than TLK-1 (data
or nontransgenic mice stained for HEL-producing cells. Original
not shown) and were therefore used primarily in our magnification, 803.
experiments. In ILK-3 transgenic mice, the rat insulin (B and D) Frozen sections (10 mm) of pancreatic islets from ILK-3
promoter directs expression of mHEL to the pancreatic transgenic or nontransgenic mice stained for HEL-producing cells.
Original magnification, 323.islet b cells. Almost all islet b cells express high levels
(E) Western blot analysis of HEL protein in various tissues from HEL-of mHEL (Figure 1B). Western blot analysis for HEL pro-
transgenic mice. NP-40 extracts from spleen, thyroid (Thyr), isletstein in thymus, spleen, and thyroid or islet lysates (Figure
(Isl), and thymus were prepared from the following mice: N, non-
1E) revealed high concentrations of HEL (140±400 ng/mg transgenic mouse; I, ILK-3; T, TLK-2; M, ML-5; and K, KLK-4. Sam-
tissue) in thyroid or islets of TLK and ILK mice respec- ples of spleen and thymus lysates (300 mg) or of thyroid (Thyr) and
tively, but no detectable protein in primary or secondary pancreatic islets (Isl) lysates (150 mg) were electrophoresed on a
15% SDS-PAGE gel, transferred to nitrocellulose, and probed withlymphoid tissues. By contrast, KLK-4 mice expressed
a monoclonal antibody to HEL. To estimate the amount of HEL inhigh concentrations of HEL in thymus and spleen. En-
each tissue, lanes were run with serial dilutions of soluble HELzyme-linked immunosorbent assay (ELISA) and fluores-
spiked into nontransgenic spleen lysates to give loaded amounts
cence-activated cell sorter (FACS) assays measured cir- of 50 ng, 10 ng, 2 ng, 400 pg, and 80 pg HEL. Closed arrow, mem-
culating sHEL in serum, probably cleaved from mHEL brane HEL (mHEL) made in ILK-3, TLK-2, and KLK-4 transgenic
(Brooks et al., 1991), at a mean concentration of 0.5 mice; open arrow, the soluble HEL (sHEL) that results from cleavage
in mHEL mice, or made as sHEL in ML-5 mice and in the standardng/ml in TLK-2 mice, 1.2 ng/ml in ILK-3 mice, 10±20 ng/
curve. The concentration of HEL protein per milligram lysate wasml in ML-5 mice, and 50±200 ng/ml in KLK-4 mice. The
estimated by densitometry; a dash indicates that tissue concentra-panel of mice thus allows analysis of tolerance to the
tion of HEL is less than 1.3 ng HEL/mg tissue (spleen and thymus)
same protein antigen at different physiological ex- or less than 2.7 ng HEL/mg tissue (thyroid and islets). Reprobing
tremes: present abundantly in primary and secondary the same blot with an antibody to actin (bottom gels) confirms that
lymphoid tissues on the one hand, or present in trace similar amounts of lysate were loaded for each tissue type, although
thyroid and islet tissues contain lower levels of actin than spleenamounts in lymphoid tissues but at high localized con-
and thymus.centrations in extralymphoid sites.
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Figure 2. Graded Degrees of CD41CD81 Cell Deletion in Thymi of (HEL 3 TCR) Double-Transgenic Mice
(A) (Top) Representative FACS analyses of thymi from nontransgenic (Non-tg.), 3A9 TCR single-transgenic (TCR-tg.) and various (HEL 3 TCR)
double-transgenic mice. The percentage of total thymocytes in each of the four gated quadrants is given in the top right corner of each plot.
(Bottom) Transgenic Va versus Vb expression from the above thymi gated for CD41CD81 (double-positive) and CD41CD82 (CD4 single-
positive) cells.
(B and C) Numbers of CD41CD81 (double-positive) (B) and CD41CD82 (single-positive) (C) cells from thymi in TCR single-transgenic and
(HEL 3 TCR) double-transgenic mice. White bars, cell numbers from CD4/CD8 gates; striped bars, cell numbers from CD4/CD8 gated cells
additionally gated for transgenic Vb8.2 and Va3 expression. Individual points, values from one mouse; bars, arithmetic mean.
Reduction in Thymocyte Numbers mice (ªTCRº) on the B10.BR (H-2k) background. All mice
used in this study were of the H-2k/b type.in Double-Transgenic Mice
To analyze the fate of autoreactive CD41 T cells in these Thymi from TCR single-transgenic H-2k/b mice do not
display a marked skewing toward the CD4 single-posi-different conditions, each of the HEL-transgenic C57BL/6
mouse lines was mated with a TCR-transgenic line (Ho tive subset (Figure 2A), a finding that has been noted
with several other class I± and class II±restricted TCRet al., 1994) carrying the a and b chain genes from the
well-characterized HEL-specific hybridoma, 3A9 (Allen transgenic mice (Schonrich et al., 1991; Geiger et al.,
1992; Bogen et al., 1993; Forster et al., 1995; Kouskoffand Unanue, 1984; Babbitt et al., 1985). The 3A9 TCR
utilizes Vb8.2 and Va3 TCR chains to recognize the et al., 1996). The cortical and medullary architecture of
the thymus is normal, however, in 3A9 transgenic ani-immunodominant HEL peptide (46±61) in the context
of I-Ak (Johnson et al., 1989). To provide the I-Ak mole- mals (data not shown). 3A9 TCR transgenic mice on the
H-2k/k background display a greater skewing to the CD4cule needed for HEL presentation, F1 (H-2k/b) double-
transgenic mice were generated by crossing the HEL- single-positive thymic subset, and this is reflected in
an increased proportion of CD41 cells expressing highexpressing C57BL/6 mice (H-2b) to 3A9 TCR transgenic
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levels of TCR transgenic Vb and Va chains in the periph- expressed on only a subset of nontransgenic lymph
ery (data not shown). Poor skewing to the CD41 subset node cells, but the intensity of staining on the positive
in H-2k/b mice (Figures 2A and 3A; see below) may be due cells was comparable to that on the TCR transgenic
to insufficient or incorrect presentation of the positive- CD41 cells (Figure 3A, top right, and Figure 3B, left).
selecting ligand or to low-level negative selection due The intensity of staining per cell for Va3 paralleled that
to an alloreactivity with H-2b. We have constructed H-2k/b of Vb8.2 in thymocytes (Figure 3A, bottom left), but devi-
(donor)→H-2k/k (recipient) bone marrow chimeras to test ated from a strict correlation in mature CD41 cells in
the possibility that there is alloreactive negative selec- lymph node and spleen (Figure 3A, bottom right). Thus,
tion to H-2b. Despite the majority of thymocytes and while almost all peripheral T cells from 3A9 mice ex-
other hematopoietic cells carrying the H-2b antigen in pressed uniform, high levels of the transgenic Vb8.2,
these chimeras, we still observed strong positive selec- expression of the transgenic Va chain was bimodal, with
tion of TCR Vahi Vbhi CD41 cells comparable to that seen one subset having high levels of Va3 (Figure 3A, small
in intact H-2k/k TCR transgenic mice (S. Townsend and arrow) and the other having 3-fold less Va3 staining per
C. C. G., unpublished data). Despite such thymic effects, cell (large arrow), presumably due to expression of an
we have found that mature peripheral T cells from both endogenous a chain. Poor allelic exclusion of the TCR
H-2k/b and H-2k/k mice proliferate similarly to HEL and a locus has been described previously in both normal
HEL 46±61 peptide in vitro (data not shown; see below). (Couez et al., 1991; Heath et al., 1995a) and TCR
Importantly, preliminary data from islet mHEL or thyroid transgenic mice (Ohashi et al., 1991; Heath and Miller,
mHEL 3 TCR double-transgenic animals on the H-2k/k 1993; Katz et al., 1993; Scott et al., 1994; Zal et al., 1994;
background support all of the findings presented below Forster et al., 1995; Munthe et al., 1995). Nonetheless,
for mice in the H-2k/b background (data not shown; see all peripheral CD41 cells in TCR single-transgenic mice
below). were positive for the transgenic Va3 well above back-
Thymi from double-transgenic mice displayed differ- ground staining levels (see overlay histogram in Figure
ent degrees of reduction in double-positive thymocyte 3B), and all responded in vitro to HEL stimulation by
cell number depending on the HEL transgene carried. CD69 induction (see Figure 6A, below).
Inheritance of the islet mHEL gene had the least effect: Spleen and lymph nodes from each (HEL 3 TCR) dou-
there was no change in thymus profile or number of ble-transgenic combination contained fewer CD41 T
CD41CD81 double-positive cells bearing transgenic Vb cells (Figures 3C and 3E). In all cases, spleen CD41
and Va in ILK-3 3 TCR double-transgenic mice com- Vb8.21 cell numbers were reduced 2- to 4-fold com-
pared to TCR single-transgenic littermates (Figures 2A pared to TCR single-transgenic mice, even in the case
and 2B). A modest effect occurred in animals expressing of islet mHEL (ILK-3 3 TCR) double-transgenic animals
thyroid mHEL, because while (TLK-1 3 TCR) and that showed no reduction in CD41CD81 thymocytes.
(TLK-2 3 TCR) thymocyte CD4/CD8 profiles resembled The number of CD41 Vb8.21 Va31 cells was reduced by
TCR single-transgenic profiles (Figure 2A), the absolute a comparable amount in each of the double-transgenic
numbers of CD41CD81 cells were reduced 3- to 4-fold mice except (KLK-4 3 TCR) animals, which displayed
(Figure 2B). In (ML-5 3 TCR) mice with abundant sHEL 10-fold fewer CD41 cells expressing both transgenic
in the systemic circulation, on the other hand, there TCR chains.
was a 32-fold reduction in CD41CD81 Vb8.21Va31 cell The peripheral CD41 cells in islet mHEL, thyroid
numbers. Finally, almost complete elimination of CD41 mHEL, and systemic sHEL double-transgenic mice had
CD81 cells occurred in (KLK-4 3 TCR) double-trans- normal CD4 levels but reduced expression of both Vb
genic mice expressing systemic mHEL on most cells and and Va transgenic receptor chains to varying degrees,
tissues (Figures 2A and 2B). The numbers of CD41CD82
depending on the HEL gene (Figure 3D). Whereas Vb8.2
single-positive thymocytes expressing transgenic Vb
and Va3 expression was only subtly reduced in islet
and Va were also reduced in each of the HEL 3 TCR
mHEL (ILK-3 3 TCR) CD41 cells, Va3 and Vb8.2 expres-
combinations (Figure 2C). While some (ML-5 3 TCR)
sion was reduced to a greater extent in thyroid mHELand all (KLK-4 3 TCR) mice had significant numbers of
(TLK-2 3 TCR) mice and greater still in systemic sHELCD41CD82 thymocytes, these cells had very reduced
(ML-5 3 TCR) mice. The latter consistently containedor absent expression of the transgenic Vb chain and
a population of CD41 cells that had little or no Vb8.2were presumably expressing an endogenous receptor
expression, presumably due to endogenous Vb expres-(Figure 2A, bottom, and Figure 2C).
sion (ML-5 3 TCR, Figure 3D). For most CD41 cells,
however, reduced TCR expression in (HEL 3 TCR) mice
was not due simply toexpression of endogenous Vb andAltered Number and Phenotype
Va chains, since CD41 Vb8.21 cells also had modulatedof Peripheral CD41 T Cells
CD3 expression (Figure 3D, bottom).In mice lacking HEL autoantigen, staining for the
In addition to the reduced numbers and TCR expres-transgene-encoded Vb8.2 and Va3 chains revealed that
sion levels, peripheral CD41 T cells from double-the majority of TCR transgenic CD41CD81 thymocytes
transgenic mice displayed the phenotype of previouslyexpressed Vb8.2 with a range of staining intensity per
activated cells. They expressed increased levels ofcell (Figure 3A, bottom left). Nontransgenic mice con-
CD44 and decreased levels of CD45RB (Figure 4). Intained few CD41CD81 thymocytes expressing Vb8.2
(ML-5 3 TCR) mice, some CD41 cells also expressed(Figure 3A, top left). In the lymph node, most TCR
the early activation marker CD69 (Figure 4), indicatingtransgenic CD41CD82 cells expressed Vb8.2 at uniform
high levels per cell (Figure 3A, bottom right). Vb8.2 was that these cells may have recently seen antigen.
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Hyporesponsiveness of Peripheral CD41 the functional ability of the peripheral CD41 T cells that
remained. Pooled spleen and lymph node cells fromCells in Double-Transgenic Mice
Since there was clear evidence for incomplete censoring individual TCR single or (HEL 3 TCR) double-transgenic
mice were used to isolate CD41 cells by positive selec-of autoreactive T cells both in the thymus and in the
periphery of the islet mHEL, thyroid mHEL, and circulat- tion on miniMACS magnetic columns. Paralleling the
different degrees of receptor modulation noted above,ing sHEL double-transgenic mice, we wanted to assess
Figure 3. Change in Peripheral T Cell Number and Phenotype in (HEL 3 TCR) Mice
(A) FACS analysis showing transgenic Vb (Vb8.2) versus Va (Va3) levels in thymus and lymph node from nontransgenic (Non) and 3A9 TCR
single-transgenic (TCR) mice. Profiles from thymus are gated for CD41CD81 cells; lymph node profiles are gated for CD41CD82 cells. Double-
negative (CD42CD82) thymocytes express little or no Vb8.2 or Va3 (data not shown), whereas double-positive thymocytes express a range
from low to high. Double-positive thymocytes that are Vb8.2hi also express high Va3, whereas peripheral CD41 cells comprise two populations:
one that has normal levels of Vb8.2 and Va3 (small arrow), and one that has normal Vb8.2 but approximately 3-fold less Va3 and presumably
coexpresses an endogenous TCR a chain (large arrow). The percentage of total thymocytes or lymph node cells in each of the four gated
quadrants is given for each plot.
(B) Overlay histograms show transgenic Vb and Va levels on CD41CD82 lymph node cells from nontransgenic (light line) and 3A9 TCR
transgenic mice (bold line).
(C) Representative FACS analysis of lymph node cells showing CD4 and CD8 cell subsets from nontransgenic (Non-tg.), 3A9 TCR single-
transgenic (TCR-tg.), and (HEL 3 TCR) double-transgenic mice expressing islet mHEL (ILK-3), thyroid mHEL (TLK-2), or systemic sHEL (ML-5).
The frequency of cells in CD41CD82 and CD4±81 gates are indicated.
(D) Decreased expression of transgenic Vb8.2 and Va3 TCR chains and CD3 on CD41CD82 lymph node cells from (HEL 3 TCR) double-
transgenic mice. Histograms of Vb8.2, Va3, and CD3 staining on CD41CD82 lymph node cells from 3A9 TCR single-transgenic mice (fine
lines) and from corresponding (HEL 3 TCR) double-transgenic mice (bold lines). Va3 and CD3 histograms are from cells gated additionally
for expression of Vb8.2.
(E) Numbers of CD41CD82 Vb8.21 cells (left) and CD41CD82 Vb8.21 Va31 cells (right) in spleens from TCR single-transgenic and (HEL 3 TCR)
double-transgenic mice. Individual points, values from one mouse; bars, arithmetic mean.
Immunity
260
single-transgenic mice results in potent B cell clonal
expansion and differentiation to produce more than 105
antibody-forming cells within 5 days. In contrast, CD41
cells from islet mHEL 3 TCR mice resulted in a 60-fold
lower antibody response, and helper activity was almost
undetectable or completely absent, respectively, in
CD41 cells from mice expressing thyroid mHEL or sys-
temic sHEL. Similar results were also obtained using
unfractionated spleen cells as T cell donors (data not
shown).
Tolerant CD41 T Cells Have Diminished
Sensitivity to TCR Stimulation
In principle, one explanation for the varying degrees
of functional impairment in the peripheral CD41 cells
described above is that the Tcells remaining after thymic
deletion were not HEL-reactive or were only poorly reac-
tive simply as a result of dilution of the transgenic Va3
by coexpressed endogenous Va chains (Figure 3D). To
test that possibility, we directly stimulated the TCR with
either anti-Vb8.2 or anti-CD3 antibody to stimulate T
cells from single- and double-transgenic mice regard-Figure 4. Changes in Cell Surface Molecules on CD4 Cells in (HEL 3
TCR) Mice less of endogenous versus transgenic Va expression.
Figure 6A shows the level of CD69 induction on CD41Expression of CD69, CD44, and CD45RB on CD41CD82 lymph node
cells from 3A9 TCR single-transgenic mice (TCR-tg.; fine lines) over- Vb8.21 spleen cells after overnight stimulation with
laid with the corresponding stain from (HEL 3 TCR) double- plate-coated anti-Vb8.2 antibody (bold lines) compared
transgenic CD41 lymph node cells (Dbl-tg.; bold lines). to cells from the same mouse cultured in control wells
with no stimulation (light lines). CD69 was rapidly in-
duced to high levels on most CD41 Vb8.21 cells from
TCR single-transgenic mice, whereas CD69 was in-CD41 cells from the different double-transgenic mice
duced on only a subset of CD41 Vb8.21 cells from dou-displayed reduced proliferative ability invarying degrees
ble-transgenic mice even though they all express Vb8.2.when stimulated with HEL protein and irradiated synge-
This was found for the range of anti-Vb8.2 antibodyneic antigen-presenting cells (Figure 5A). Thus, CD41
concentrations tested (from 1 to 30 mg/ml) (Figure 6B).cells from islet mHEL (ILK-3 3 TCR) animals had moder-
In addition, lower levels of CD69 were induced on theately reduced proliferation to HEL; cells from thyroid
subset of responding cells from double-transgenic micemHEL mice were further reduced; and cells from sys-
compared to the uniform high levels achieved on CD41temic sHEL (ML-5 3 TCR) mice did not proliferate. To
cells from TCR single-transgenic mice (Figure 6A). Fi-assess whether hyporesponsiveness could be reversed
nally, paralleling stimulation with HEL, splenocytes fromby addition of interleukin-2 (IL-2), as is the case with
double-transgenic mice proliferated less well to anti-anergic T cells in vitro (Mueller and Jenkins, 1995), CD41
Vb8.2 antibody than did the TCR single-transgeniccells were also stimulated in the presence of HEL and
splenocytes (Figure 6C). Similar results were observedIL-2. Proliferative capacity of CD41 cells from (ILK-3 3
using anti-CD3 stimulation (data not shown). Thus, inTCR) and (TLK-2 3 TCR) mice was not increased with
both the CD69 and proliferative responses, graded de-IL-2, but cells from (ML-5 3 TCR) did show modest
grees of hyporesponsiveness to anti-Vb8.2 were ob-proliferation to HEL when IL-2 was added (Figure 5B).
served with cells from islet mHEL responding betterThe CD41 cells from each type of mouse nevertheless
than those from thyroid mHEL, and systemic sHEL cellsresponded comparably to phorbol dibutyrate and iono-
responding the least.mycin (data not shown), suggesting that a specific deficit
in membrane-proximal signaling components rather
than a general defect may be responsible for the im- Hyporesponsive T Cells Spontaneously Infiltrate
Thyroid Glands and Pancreatic Isletspaired response to HEL. Similar data were also obtained
in cultures of unfractionated spleen cells from (HEL 3 Because peripheral CD41 autoreactive cells from islet
mHEL and thyroid mHEL animals could still be stimu-TCR) double-transgenic mice (data not shown).
To further characterize the functional impairment of lated weakly by high concentrations of HEL in vitro,
histological analysis of pancreas and thyroid was per-CD41 cells from (HEL 3 TCR) double-transgenic mice,
purified CD41 cells were tested in a sensitive in vivo B formed to see if the high local concentrations of HEL
in these sites (Figures 1A, 1B, and 1E) would breakcell helper assay (Rathmell et al., 1995). In brief, TCR or
(HEL 3 TCR) CD41 T cells were mixed with anti-HEL tolerance.Littermate controlTLK-2 and ILK-3 transgenic
mice that did not inherit the TCR transgene did notimmunoglobulin transgenic B cells and injected into irra-
diated soluble HEL-expressing mice to provide a source display noticeable spontaneous infiltration of HEL-
expressing tissue (Figures 7A and 7E). By contrast, allof antigen and sites for T±B collaboration. As can be
seen in Figure 5C, injection of CD41 cells from TCR thyroids from (TLK-2 3 TCR) double-transgenic mice
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and greater than 90% of islets from (ILK-3 3 TCR) dou-
ble-transgenic mice were extensively infiltrated by lym-
phocytes in all animals examined (n > 16 for each type)
(Figures 7B and 7F). Despite the extensive, spontaneous
insulitis and thyroiditis, at all ages the mice retained
large numbers of HEL-expressing thyroid or islet cells
(Figures 7B and 7F) and developed no signs or symp-
toms of diabetes or hypothyroidism, respectively. In
both sets of double-transgenic mice, infiltrates con-
sisted of numerous Vb8.21 cells (Figures 7B and 7F), as
well as large numbers of B cells and some activated
macrophages (data not shown). The latter two cell sub-
sets likely represent the bulk of the many class II±
positive cells seen in the inflamed tissue. Class II expres-
sion was also apparent on parenchymal tissue in
infiltrated organs (e.g., thyroid epithelium; Figures 7B
and 7F).
To test the notion that spontaneous thyroiditis in
(TLK-2 3 TCR) double-transgenic mice was due to reac-
tivation of partially tolerized autoreactive T cells by high
local concentrations of autoantigen, we exploited the
fact that T cells were more profoundly hyporesponsive
in (ML-5 3 TCR) mice with higher systemic sHEL antigen.
To this end, we generated (ML-5 3 TLK-2 3 TCR) triple-
transgenic mice in which higher concentrations of circu-
lating sHEL were present in addition to high local
amounts of thyroid mHEL. These mice had similar thy-
mus and peripheral T cell number and phenotype as
(ML-5 3 TCR) double-transgenic mice (data not shown).
Unlike the case with (TLK-2 3 TCR) mice, however,
thyroids from triple-transgenic mice were completely
protected from spontaneous infiltration (n 5 4) (Figure
7C). Thus, HEL-specific T cells in systemic sHEL mice
are driven into a deeper state of tolerance that cannot
be broken by high localized expression.
Endogenous Va and Vb Expression Are Not
Required for Incomplete Tolerance
and Spontaneous Autoimmunity
in (TLK-2 3 TCR) Mice
While it was clear that HEL-reactive T cells were present
in the periphery of organ-specific (HEL 3 TCR) double-
transgenic mice described above, it was possible that
their escape from thymic deletion and infiltration of en-
docrine tissues depended upon coexpression of an en-
dogenous Va chain (Heath et al., 1992; Zal et al., 1994;Figure 5. The Functional Capacity of CD41 Cells from (HEL 3 TCR)
Kouskoff et al., 1996). Like most TCR transgenic mice,Double-Transgenic Mice Is Reduced to Different Degrees
3A9 mice contain many cells that appear to expressCD41 cells were purified from spleen and lymph node by staining
both the transgenic and an endogenous TCR a chaincells with magnetic anti-CD4 microbeads and passing through a
miniMACS column. Percentage of purified Vb8.21 cells that were (Figure 3A), and this may be exaggerated in (HEL 3 TCR)
CD41 was 82%±92%. double-transgenic animals (Figure 3D). To eliminate re-
(A) CD41 cells were stimulated in the presence of irradiated synge- arrangement and expression of endogenous TCR genes,
neic spleen cells with increasing concentrations of HEL for 3 days.
(TLK-2 3 TCR) mice were bred onto theRAG-2 knockout[3H]Thymidine was added for an additional 12 hr of stimulation.
Shown are the mean and standard deviation of [3H]thymidine incor-
poration from triplicate samples of CD41 cells from two different
mice of each type at each dose of HEL. The low number of counts
is due to inefficiency of the b-particle plate reader, which is generally spleen cells from immunoglobulin transgenic mice containing naive
5%±10% of counts detected by conventional scintillation. HEL-specific B cells into irradiated sHEL-expressing recipients to
(B) Analysis as in (A), but with 30 units/ml of recombinant IL-2 added provide a source of antigen for collaboration and clonal expansion.
at the start of the culture. Two Tcell donors of each typewere tested separately in two or three
(C) In vivo assay to measure the ability of T cells to activate and irradiated sHEL recipient mice for each. The number of antibody-
help B cell antibody production. The genotype of the donors of forming cells (AFCs) per spleen 5 days after adoptive transfer is
purified CD41 cells are indicated at the bottom. CD41 cells (2 3 shown. Individual points, values from one recipient mouse; bars,
105) from each type of mouse were adoptively transferred with arithmetic mean.
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Figure 6. Sensitivity to TCR Stimulation Is Reduced to Different Degrees in CD41 Cells from HEL 3 TCR Double-Transgenic Mice
(A) Induction of CD69 expression on Vb8.21 cells after 14 hr stimulation with plate-bound F23.2 (anti-Vb8.2; 10 mg/ml) monoclonal antibody
or HEL (20 mM). Spleen cells from nontransgenic (non-tg.), 3A9 TCR transgenic (TCR-tg.), or the indicated (HEL 3 TCR) double-transgenic
mice were cultured and then stained for expression of CD4, the transgenic Vb8.2, CD69, and for viability. Histograms shown by fine lines are
CD69 levels of gated CD41 Vb8.21 viable cells from control (unstimulated) cultures; bold lines are identically gated cells from cultures stimulated
with anti-Vb8.2 or HEL antigen. Note that whereas all cells from TCR single-transgenic mice respond to anti-Vb8.2 with high levels of CD69,
a subset of Vb8.21 CD41 cells from double-transgenic mice do not respond and the remainder respond with lower levels of CD69.
(B) Median scaled CD69 fluorescence on CD41 Vb8.21 cells cultured with different concentrations of plate-bound F23.2 as in (A). Each line
represents median fluorescence values from two mice of each type.
(C) Proliferation of unfractionated spleen cells stimulated as in (A) with different concentrations of plate-bound F23.2 for 3 days. [3H]thymidine
was added for an additional 12 hr of stimulation. Shown are mean and standard deviation of [3H]thymidine incorporation for triplicate samples
of spleen cells from two different mice of each type at each dose of F23.2.
(RAG-22/2) background (Shinkai et al., 1993). Thymus provide help to B cells (Figure 8C) and in proliferation
to HEL in vitro (data not shown). Histological examina-profiles from RAG-22/2 single and double-transgenic
mice (Figure 8A) mimicked exactly those of RAG-2± tion of thyroids from these mice revealed lymphocytic
infiltration of the thyroid glands (Figure 7D), althoughexpressing mice, and CD41CD81 thymocyte numbers
were again reduced 2- to 3-fold in mice carrying the the incidence of thyroiditis was reduced (54% inTLK-2 3
TCR, RAG-22/2 [n 5 13] compared to 100% in RAG-thyroid mHEL transgene (Figure 8B). Spleen and lymph
node from TCR1 RAG-22/2 mice contained markedly 21/1 double-transgenic mice [n 5 31]). The severity of
thyroiditis in the affected RAG-22/2 was also lower com-fewer CD41 T cells (2 3 105 in TCR1 RAG-22/2 mice,
compared to 6.5 3 106 in TCR1 RAG-21/1 mice; Figures pared to RAG-21/1 double-transgenic mice. While these
differences could reflect the overall reduced frequency8A and 8B). It is possible that 3A9 TCR1 T cells require
a normal splenic architecture, including B cells, for sur- of CD41 cells, or absence of B cells or other TCR speci-
ficities, the fact that spontaneous thyroiditis occurredvival in the periphery, since RAG-22/2 mice lack these
elements. in the RAG-22/2 animals indicates that coexpression
of endogenous TCR a chains is not essential for HEL-In thyroid mHEL 3 TCR double-transgenic mice on
the RAG-22/2 background, there were 25-fold fewer pe- specific autoreactive T cells to escape central tolerance
mechanisms and initiate autoimmune pathology in sitesripheral CD41 cells than their TCR1 RAG-22/2 littermates
(Figures 8A and 8B). The remaining peripheral CD41 of abundant autoantigen.
cells in double-transgenic, RAG-22/2 mice nevertheless
carried the transgene-encoded Vb8.2 and Va3, although Discussion
both of these were modulated approximately 2-fold rela-
tive to TCR single-transgenic, RAG-22/2 mice (Figure 8A, The abovefindings reveal a spectrum of tolerance induc-
tion in autoreactive CD4 T cells resulting from differ-rightmost columns). Despite expressing the transgenic
TCR, the autoreactive peripheral T cells in TLK-2 3 TCR, ences in the distribution and amount of self-antigen
(summarized in Figure 9). In the case of systemicallyRAG-22/2 mice were greatly reduced in their ability to
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expressed mHEL, thymic censoring efficiently elimi- cells. While the thyroid gland is one of the most vascu-
larized organs in the body, antigens such as mHEL onnates self-reactive T cells, but these mechanisms are
incomplete for systemic sHEL and thyroid mHEL, and the thyroid epithelium may have limited access to the
immune system because of an intact endothelial barrier.virtually ineffective for islet mHEL. Peripheral CD41 HEL-
reactive T cells also display graded degrees of tolerance Sequestration of organ-specific antigens may be most
extreme for those behind the blood±brain barrier, suchinduction as measuredby lower cell numbers, TCR mod-
ulation, diminished in vitro responsiveness to HEL, and as MBP. Consistent with this, circulating CD41 T cells
in anti-MBP TCR transgenic mice do not show evidencepoor in vivo ability to provide B cell help. Impaired func-
tion of autoreactive T cells represents an intrinsic of antigen exposure (Lafaille et al., 1994), unlike the
activated phenotype seen in ILK-3 3 TCR and TLK-2 3change in the sensitivity to TCR stimulation, rather than
a loss of specific HEL reactivity. Nonetheless, as re- TCR mice studied here and in several other organ-spe-
cific TCR transgenic models (Scott et al., 1994; Alferinkvealed by in vitro stimulation and in vivo infiltration of
thyroid and islets, T cells that are partially tolerant to et al., 1995; Antonia et al., 1995; Kouskoff et al., 1996).
The size of the organ and fraction of cells expressingorgan-specific antigens can become activated, particu-
larly upon encounter of high localized expression of the antigen are also likely to be important for active
tolerance induction. Differences in the mass of the thy-antigen. The occurrence of this reactivation without sub-
sequent tissue destruction and endocrine insufficiency roid versus pancreatic islet endocrine tissue may thus
explain the less effective tolerance to mHEL in ILK-3raises the possibility that these T cells may under differ-
ent circumstances actively promote or inhibit organ- compared to TLK-2 mice, although mHEL was detected
at higher concentrations in ILK-3 islets compared tospecific autoimmunity.
TLK-2 thyroid (Figure 1E). The difference between these
lines of mice could nevertheless be equally explained
Factors Affecting Actively Acquired Tolerance by differences in thymic expression or in the types of
in CD4 Cells antigen-presenting cells or vasculature of the two or-
Thymic expression of antigen results in deletion or an- gans. Expression of antigen by only a fraction of b cells
ergy induction of specific T cells (Kisielow et al., 1988; may similarly explain the limited tolerance in TCR 3 RIP-
Sha et al., 1988; Berg et al., 1989; Pircher et al., 1989; SV40 T antigen transgenic mice, where active T cell
Vasquez et al., 1992; Bogen et al., 1993; Kouskoff et tolerance only occurred when the T cell precursor fre-
al., 1996; Oehen et al., 1996), as illustrated here by the quency was lowered (Forster et al., 1995). In contrast
complete deletion of double-positive thymocytes in to the variegated expression in RIP-SV40 transgenic
KLK-4 3 TCR mice with mHEL expression under a class mice, the majority of islet cells in ILK-3 mice expressed
I MHC promoter (Figures 2A and 2B). Autoantigen syn- mHEL (Figure 7E), and (ILK-3 3 TCR) double-transgenic
thesized in peripheral tissue and shed or secreted into mice accordingly displayed functional tolerance in the
the circulation may also trigger thymic deletion (Zal et T cell compartment even when almost all CD41 T cells
al., 1994) , as observed in ML-5 3 TCR mice with 10±20 are specific for HEL.
ng/ml sHEL in the circulation. Expression of mHEL spe- Differences in TCR avidity should also determine the
cifically in the pancreatic islet b cells, on the other hand, extent to which autoreactive T cells are actively tolerized
induced no deletion at the double-positive stage, al- upon thymic or peripheral antigen exposure. The 3A9
though these mice have a mean concentration of 1.2 TCR used here recognizes an immunodominant epitope
ng/ml of shed HEL in the circulation. Curiously, slightly of HEL and is very sensitive to HEL antigen (Allen
reduced numbers of CD41CD81 thymocytes were ob- and Unanue, 1984; Brooks et al., 1991; Brooks and
served in TCR transgenic mice expressing HEL specifi- McCluskey, 1993). However, it is clear from staining for
cally in the thyroid (Figures 2A and 2B) despite the fact the transgenic Va3 (Figure 3B) that many CD41 cells in
that TLK-2 mice have less circulating HEL (mean of 0.5 3A9 mice have reduced avidity because the transgene-
ng/ml). Although Western blot and reverse transcription encoded receptor is diluted 2- to 3-fold by other non-
polymerase chain reaction analyses for HEL protein and Va3 receptors. Most of the T cells that are present in
mRNA, respectively, from TLK-2 transgenic mice did the thyroid mHEL or islet mHEL double-transgenic mice
not reveal thymic expression of HEL (Figure 1E; S. A., appear to be the low-avidity type (Figure 3D). High-
unpublished data), low levels in rarecells may be difficult avidity cells may be more stringentlydeleted, since there
to detect. Several lines of transgenic mice using ªtissue- was a larger magnitude reduction in peripheral CD41
specificº promoters also express the transgene in the cells in the presence of thyroid mHEL on a RAG-22/2
thymus, recapitulating thymic expression of theendoge- background (Figure 8B). Nevertheless, it is clear that
nous gene (Miller and Heath, 1993; Jolicoeur et al., 1994; some high-avidity cells reach the periphery and the thy-
Antonia et al., 1995). It is also conceivable that antigen- roid in the RAG-22/2 mice (Figures7D and 8B).Moreover,
presenting cells acquire antigen in the thyroid gland, the low-avidity cells in RAG-21/1 thyroid mHEL or islet
where it is abundant, and bring it to the thymus. mHEL animals still retain significant HEL reactivity in
In the case of organ-specific antigens, the organ vas- vitro that is sufficient to mediate thyroiditis or insulitis
culature may influence availability of antigens to the in vivo.
immune system and their capacity to trigger active toler- Differences in TCR avidity and antigen presentation
ance. Antigens on hepatocytes may be more tolerogenic may partly explain the lack of active tolerance observed
than those on the parenchyma of other organs such as in other TCR transgenic models of CD4 cell organ-spe-
skin or brain (Arnold et al., 1994) because the open cific tolerance. For example, although MBP is expressed
vasculature of the liver makes the parenchyma accessi- at low levels in the thymus (Grima et al., 1992; Mathisen
et al., 1993; Pribyl et al., 1993), deletion is not triggeredble to circulating lymphocytes and antigen-presenting
Immunity
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Figure 7. Spontaneous Thyroiditis or Insulitis in Thyroid mHEL 3 TCR and Islet mHEL 3 TCR Double-Transgenic Mice: Prevention by Systemic
sHEL Coexpression but Not by Elimination of Endogenous TCR Gene Rearrangements
(A±F) Representative thyroid and pancreas sections from single, double, and triple-transgenic mice, as indicated on the left. Tissue staining
is indicated above. H/E, hematoxylin and eosin stains of paraffin embedded sections; HEL, staining for HEL-producing cells using HyHEL-9
antibody; open arrows indicate thyrocytes or islet cells expressing HEL (A±F); Vb8.2/Thy1.2, staining with anti-Vb8.2 (A, B, E, and F) or anti-
Thy1.2 (C and D) antibody; arrowhead, example of Vb8.2- or Thy1.2-positive inflammatory cell (B, D, and F); class II, staining with a pan±anti-
class II antibody; closed arrow indicates an example of infiltrating cells or inflamed thyroid epithelium expressing class II (B, D, and F). For
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in three different anti-MBP TCR transgenic mice (Gover- for controlling peripheral CD4 and CD8 T cells of inter-
mediate avidity for self-antigen.man et al., 1993; Lafaille et al., 1994; Liu et al., 1995).
Injection of large amounts of MBP Ac1±11 could not Despite displaying a reduced capacity to respond to
HEL, autoreactive T cells in (islet mHEL 3 TCR) andinduce thymic deletion in one of these lines (Liu et al.,
1995), suggesting either that the affinity of this patho- (thyroid mHEL 3 TCR) double-transgenic mice could
nonetheless be partially reactivated by high concentra-genic TCR is low or that the peptide is inefficiently pre-
sented. Along similar lines, tolerance to influenza HA tions of HEL in vitro (Figures 5A and 5B) or by high local
expression of lysozyme in vivo as judged by the 100%expressed in pancreatic islets appeared less complete
to the HNT peptide epitope than to the SFE peptide incidence of insulitis and thyroiditis, respectively (Fig-
ures 7B and 7F). Thyroiditis was prevented in triple-epitope from the same protein (Lo et al., 1992). In the
comparable TCR transgenic model, no active tolerance transgenic mice in which elevated systemic sHEL was
coexpressed with thyroid mHEL (Figure 7C). The latteroccurred in (HNT TCR 3 Ins-HA) mice (Scott et al., 1994),
whereas peripheral CD41 cells from (anti-SFE TCR 3 result can be interpreted in several ways. First, because
thymic censoring appears more stringent to systemicIns-HA) mice had reduced in vitro proliferative re-
sponses (Degermann et al., 1994) similar to those ob- sHEL than to thyroid mHEL (Figure 2B), the HEL-reactive
cells that escape thymic censoring may have been se-served in ILK-3 3 TCR mice here.
The escape of some low avidity, functionally hypore- lected for low TCRa densities and thus have too low an
avidity to become activated by high localized expressionsponsive T cells from thymic deletion in ML-5 3 TCR
mice expressing sHEL is consistent with earlier work by in the thyroid (similar to a conclusion by Heath et al.,
1992). Alternatively, constant exposure to higher levelsYule et al. (1993). They concluded that not all autoreac-
tive CD41 T cells to the immunodominant 46±61 epitope of HEL antigen in the periphery of ML-51 mice could
induce a deeper level of hyporesponsiveness or alteredare deleted in ML-5 H-2k/b mice because proliferative
responses and clones could be established following trafficking pattern in remaining autoreactive T cells.
immunization with large amounts of antigen. These T
cell clones required much more antigen to respond, Regulation of Progression from Inflammation
consistent with the findings here. A similar escape of to Endocrine Insufficiency
low-avidity and/or hyporesponsive T cells was found for It isstriking that despite the large numberof autoreactive
complement C5a-reactive CD41 cells (Zal et al., 1994) CD4 cells and florid inflammation produced in islet-HEL
and beef insulin±reactive CD41 cells in beef insulin or thyroid-HEL 3 TCR double transgenic mice, diabetes
transgenic mice (Poplonski et al., 1996). or hypothyroidism does not occur. Subclinical lympho-
cytic thyroiditis similar to that observed here occurs in
5%±20% of euthyroid people and highlights two long-Partial Responsiveness of Autoreactive T Cells
Peripheral CD41 cells in ILK-3, TLK-2, or ML-5 3 TCR standing questions: First, what induces subclinical organ
inflammation and autoimmunity at such high incidence?double-transgenic mice displayed slightly modulated
TCR levels and graded degrees of hyporesponsiveness Second, what controls the progression to clinical auto-
immune thyroid insufficiency that happens in only ato antigen as measured by CD69 induction, prolifera-
tion, and helper function (Figures 5A±5C). Hyporespon- small fraction of these people (Weetman, 1991)?
The spectrum of tolerance in CD4 T cells observedsiveness was not simply a result of loss of HEL-specific
receptor because direct stimulation of the TCR with here together with that in other models (Figure 9) implies
that, in health, a range of self-reactive CD4 clones nor-monoclonal antibodies also elicited a poor response
(Figures 6A±6C). These results, as well as the CD44hi mally escape from the thymus and become potentially
available to initiate autoimmune inflammation. Depend-CD45RBlo phenotype, are strikingly similar to findings in
a number of other autoreactive TCR transgenic toler- ing on theaffinity of the particular TCR and the amount of
self-peptide/MHC presented in primary and secondaryance models (Schonrich et al., 1991; Fields and Loh,
1992; Schonrich et al., 1992b; Alferink et al., 1995; An- lymphoid tissues, these clones will be functionally inacti-
vated or physically deleted to varying extents. In thetonia et al., 1995; Forster et al., 1995; Kouskoff et al.,
1996). These phenotypic and functional characteristics case of organ-specific antigens, the graded nature of
functional inactivation and deletion allows some autore-are also reminiscent of those seen in a number of super-
antigen-mediated tolerance models (Fink et al., 1992; active CD4 clones to escape both processes and remain
fully responsive (Goverman et al., 1993; Katz et al., 1993;Miethke et al., 1994; Perkins et al., 1994; Dillon et al.,
1995; Renno et al., 1996), as well as TCR transgenic Lafaille et al., 1994; Liu et al., 1995). Other clones are
partially inactivated such that they can make a limitedmodels for peripheral tolerance to systemic antigen (Hu-
ang et al., 1994; Kearney et al., 1994; Rocha et al., 1995; response when exposed to antigen at high concentra-
tions such as occurs within the organ (e.g., islet-HELZhang et al., 1996). Collectively, these findings indicate
that functional inactivation is a widespread mechanism and thyroid-HEL reactive cells here) (Degermann et al.,
specific antibody staining, 7±10 mm serial frozen sections were stained with biotinylated primary antibody, then avidin±alkaline phosphatase
second step, and then Fast Red substrate and hematoxylin counterstain. In each case, specific staining is red, and counterstain (nuclei) is
blue. Thyroid and islet preparations from nontransgenic mice did not show specific staining with any of the primary antibodies used. Original
magnifications for each set of four slides are as follows: (A) 803, 403, 403, and 403; (B) 803, 483, 483, and 483; (C) 1003, 1003, 1003,
and 1003; (D) 1203, 803, 803, and 803; (E) 643, 803, 803, and 803; and (F) 483, 1203, 1203, and 1203.
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Figure 8. Fate of Autoreactive T Cells in Thyroid mHEL 3 TCR Double-Transgenic Mice on the RAG-22/2 Background Recapitulates Results
in the RAG-21/1 Background
(A) FACS analysis of thymus and spleen from RAG-22/2 nontransgenic (non), 3A9 TCR single-transgenic (TCR), and (TLK-2 3 TCR) double-
transgenic mice. Numbers within each plot are the frequencies of cells in each gated quadrant. Vb8.2 histograms are gated on CD41CD82
spleen cells, and Va3 histograms are from CD41CD82 Vb8.21 cells. In each panel, histograms shown with a fine line are from TCR single-
transgenic mice (TCR-tg.) to show control staining on nontolerant T cells.
(B) Numbers of T cells in RAG-22/2 mice from flow cytometry as in (A). Numbers of CD41 CD81 cells in thymus and the number of CD41CD82
Vb8.21 cells in spleen are shown from individual mice (dots) of the indicated genotypes. Bars, arithmetic mean.
(C) In vivo assay for capacity to help B cells in an adoptive transfer antibody response as described in Figure 5C. In this case, T cells were
from pooled spleen and lymph nodes from either RAG-21/2 or RAG-22/2 mice of the indicated transgene genotype.
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Figure 9. Model for Graded Tolerance in
Class II±Restricted Autoreactive T Cells
Graded triggering of functional inactivation or
physicaldeletion are hypothesized to depend
on the amount of autoantigen presented in
lymphoid tissues and the affinity with which
it is bound by a given TCR. Models described
in the present study as well as corresponding
examples from the literature are indicated.
1994; Scott et al., 1994; Forster et al., 1995). Spontane- has been found for the regulatory CD4 cells of similar
phenotype defined by Mason, Powrie, and othersous organ inflammation is commonly observed when
(Weiner et al., 1994; Powrie, 1995). It will be importantthe frequency of these organ-specific clones is greatly
in future work to analyze the regulatory function andelevated in TCR transgenic mice, but progression to
spectrum of cytokines made by the partially inactivateddisease either does not occur, as seen here, or begins
CD4 cells described here and to examine whether themuch later (Katz et al., 1993).
quality of their response changes when inherited allelesAutoreactive CD8 cells may represent one additional
at the MHC or other loci are permissive to tissue de-promoting factor required for progression from subclini-
struction.cal inflammation to tissue destruction. It is noteworthy
that most class I±restricted TCR transgenic models for
Experimental Proceduresorgan-specific tolerance have not demonstrated spon-
taneous tissue infiltration (Ohashi et al., 1991; Schonrich Transgenic and Knockout Mice
et al., 1991, 1992a; Miller and Heath, 1993; Alferink et The generation of KLK-4 and ML-5 HEL transgenic mice has been
al., 1995). The different TCR transgenic findings together previously described (Goodnow et al., 1988; Hartley et al., 1991).
To direct expression of mHEL specifically to the thyroid, a 3.3 kbwith adoptive transfer or antibody depletion experi-
fragment of the rat thyroglobulin promoter (Avvedimento et al., 1985;ments in autoimmune animals with nontransgenic T cell
Musti et al., 1986) was substituted for the class I promoter used inrepertoires (Parish et al., 1995) suggest that CD41 cells the KLK-4 line and used to produce the TLK-1 and TLK-2 transgenic
are often required to initiate autoimmune infiltration by lines. Similarly, the ILK-3 transgenic line was created by using 600bp
CD81 cells. The CD8 cells in turn may be more efficient of the rat insulin promoter (Adams et al., 1987) to direct expression of
mHEL to the pancreatic islet b cells. The generation of these mouseat destroying the inciting tissue.
lines will be described in more detail in a subsequent publicationProgression from subclinical organ inflammation to
(S. A., unpublished data). In each of these lines, HEL is anchoreddestructive autoimmune disease may also hinge on
to the plasma membrane with the class I H-2Kb transmembrane
qualitative changes in the autoimmune response by ig- region (Hartley et al., 1991). The 3A9 anti-HEL TCR transgenic and
norant or hyporesponsive CD4 cells. Thus, while the MD4 anti-HEL immunoglobulin transgenic lines have been pre-
viously described (Goodnow et al., 1988; Ho et al., 1994). Exceptpartial activation of hyporesponsive autoreactive CD4
for mice bred to the RAG-22/2 background, nontransgenic, HELcells observed here appears sufficient to initiate and
transgenic, TCR, immunoglobulin, and double-transgenic mice werepromote organ inflammation, perhaps through the in-
generated as (B6 3 B10.BR)F1 mice, giving the H-2k/b MHC haplo-
duction of an inflammatory cytokine or chemokine, this type. RAG-2 knockout mice (RAG-22/2) were obtained from Fred Alt
response is insufficient to bring about tissue destruction and were generated on the 129 strain background (Shinkai et al.,
1993). (TLK-2 3 TCR)F1 animals were crossed to RAG-22/2 mice toand clinical endocrine insufficiency. Inflammation may
generate RAG-21/2 animals. These mice were then intercrossed tonot progress to disease because thepartially inactivated
create (TLK-2 3 TCR) RAG-22/2 animals that were also H-2k/b. AllT cells, like T cells stimulated with low doses of peptide
animals were screened by polymerase chain reaction; primer se-
(Hosken et al.,1995), low doses of antigen peros (Weiner quences are available by request. Serum concentrations of HEL in
et al.,1994), or altered peptide ligands that weaklystimu- TLK-1, TLK-2, and ILK-3 were measured by FACS quantitation of
bound HEL on anti-HEL immunoglobulin transgenic B cells (Good-late the TCR (Evavold et al., 1993), are unable to produce
now et al., 1989) because this method is more sensitive than ELISA.tissue destructive cytokines such as g interferon. In ad-
dition, partially inactivated CD4 cells may selectively
Western Blot for HEL Detection
synthesizecytokines such as transforming growth factor Spleen, thymus, and thyroids were removed from the various mice
b that curtail tissue destruction, and thus actively sup- (one mouse per tissue) and immediately minced in ice-cold phos-
phate-buffered saline (PBS) using a 5 ml glass and Teflon tissuepress destructive inflammation by ignorant clones, as
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grinder (PGC Scientific, Gaithersberg, MD). Islets from five mice of were washed three times with PBS before the addition of cells. For
stimulation with specific antigen, HEL (Sigma, St. Louis, MO) waseach type (nontransgenic and ILK-3 transgenic) were prepared as
added to cells at different concentrations. Cells were incubated atdescribed (Katz et al., 1993), pooled, and similarly minced as above.
378C, 5% CO2. Cells stimulated overnight were analyzed by flowSpleen and thymus were lysed at a concentration of 10 mg tissue/
cytometry for CD69 induction. Dead cells were eliminated by stain-ml and thyroid and islets were lysed at a concentration of 5 mg
ing with propidium iodide. Parallel cell cultures were stimulatedtissue/ml in 1% NP-40 using lysis conditions as described (Healy
for 3 days; proliferation of cells was analyzed by the addition ofet al., 1997). Thirty microliters of lysates (300 mg of spleen and
[3H]thymidine for an additional 12 hr to the culture. Plates werethymus and 150 mg of thyroid and islets) were run on a 15% SDS±
harvested onto glass filter paper and dried, and b-particle emissionpolyacrylamide electrophoresis (SDS-PAGE) gel under nonreducing
was counted on a Matrix 96 Direct Beta Counter (Packard Instru-conditions. HEL was detected using HyHEL-9-biotin, streptavidin-
ments, Meridian, CA). The raw cpm obtained using this methodHRP second stage (Amersham), and Renaissance detection system
are considerably lower than when detected by conventional liquid(NEN Life Sciences, Boston, MA). To estimate the amount of HEL
scintillation.in each tissue, nontransgenic spleen lysates were spiked with serial
dilutions of HEL (Sigma, St. Louis, MO). Autoradiograms were ana-
T Cell Assay for B Cell Helplyzed with a Molecular Dynamics Computing Densitometer and Im-
Unfractionated spleen or purified CD41 donor cells were preparedageQuant software (Molecular Dynamics).
as described above and analyzed by flow cytometry for frequency
of CD41 Vb8.21 cells. Recipient animals in adoptive transfer assays
Flow Cytometry
were 750 rad±irradiated (B6 3 B10.BR)F1 ML-5 soluble HEL
Spleen, lymph node, and thymus cells were isolated by passing transgenic mice. Equal numbers of CD41 Vb8.21 cells from each T
through a metal sieve, washed in media containing 2% fetal calf
cell donor type were mixed with 1 3 107 spleen cells from a (B6 3
serum/RPMI 1640, and counted with a hemocytometer as described B10.BR)F1 anti-HEL immunoglobulin transgenic mouse and injected
(Goodnow et al., 1988; Hartley et al., 1991). Cells were analyzed into ML-5 irradiated recipients via the lateral tail vein. After 5 days,
by flow cytometry on a customized dual laser FACS-2 (Becton- recipient mice were sacrificed and spleen cell preparations were
Dickinson, Mountain View, CA) with FACS Desk software (Beckman made as described above. Cells were counted by hemocytometer
Center Shared FACS Facility). The following antigens and antibodies and suspended to appropriate concentrations for flow cytometric
were used: B220, RA3±6B2-phycoerythrin (PE) (Caltag, South San analysis or spot ELISA (Goodnow et al., 1989) to determine the
Francisco, CA) and RA3±6B2±fluorescein isothiocyanate (FITC) (Cal- frequency of anti-HEL IgMa-secreting cells.
tag); Thy1.2, CT-Th1-biotin (Caltag); Ly5a, AS20-FITC, and AS20-
biotin; CD4, GK-1.5-allophycocyanin (a gift from J. Altman and E. Preparation of Histological Samples
Kerr) and YTS191.1-PE (Caltag); CD8a, YTS169.4-PE (Caltag); CD69, Thyroid or pancreas was removed from sacrificed animals and
H1.2F3-FITC (Pharmingen, San Diego, CA); CD44, IM7-PE (Phar- placed into plastic containers for paraffin embedding (Monosette,
mingen); CD45RB, 23G2-biotin (Pharmingen); Vb8.2, F23.2-biotin; VWR, San Francisco, CA) or frozen sections (Cryomold, Miles, Elk-
CD3, 500A2 (Pharmingen); and Va3, rabbit anti-Va3 antiserum (Ho hart, IN). Tissue samples for paraffin embedding were immediately
et al., 1994). Biotinylated reagents were detected with streptavidin± placed in 10% neutral buffered formalin for fixation and sent to a
Texas Red (Vector Labs, Burlingame, CA). Hamster anti-CD3 anti- commercial laboratory for embedding, sectioning, and hematoxylin
body was detected with anti-hamster-FITC second-stage reagent and eosin staining. Tissue samples for frozen sections were immedi-
(Jackson Immunoresearch,West Grove, PA). Rabbit anti-Va3 antise- ately covered in optimal cutting temperature medium (Miles), slowly
rum was detected with donkey anti-rabbit-FITC second stage re- frozen by floating on liquid nitrogen, and stored at 2808C until cut.
agent (Jackson Immunoresearch). Except for Va3 staining, all anti- Sections, 6±10 mm, were cut on a microtome at 2208C and collected
body stains were performed on 5 3 105 cells using standard onto PTFE-coated slides (Hendley-Essex; Essex, England).Sections
procedures as described (Goodnow et al., 1988). To stain for Va3, were dried overnight, fixed for 10 min in acetone (at 48C),and stained
in a humid chamber at room temperature with a biotinylated primaryair-fuged anti-Va3 antiserum was first incubated for 10 min at room
antibody as described (Mason et al., 1992). The following primarytemperature in 2% normal rat serum and 2% normal mouse serum
antibodies were used: anti-HEL (HyHEL-9), anti-Vb8.2 (F23.2), anti-and then put onto cells for 20 min on ice. Cells were then washed
Thy1.2 (CT-Th1, Caltag), and pan±anti-class II (7±16.17, Phar-and incubated with 2% normal mouse serum/normal rat serum for
mingen). Avidin±alkaline phosphatase second stage (Sigma) and10 min on ice to remove residual nonspecific reactivity. Finally,
Fast Red/Naphthol AS-MX substrate (Sigma) were used to visualizeanti-rabbit-FITC second-stage antibody was added to the cells for
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